Literature DB >> 19152384

Evidence for an interaction of schizophrenia susceptibility loci on chromosome 6q23.3 and 10q24.33-q26.13 in Arab Israeli families.

A Alkelai1, Y Kohn, T Olender, K Sarner-Kanyas, A Rigbi, A Hamdan, E Ben-Asher, D Lancet, B Lerer.   

Abstract

A genome scan for schizophrenia related loci in Arab Israeli families by Lerer et al. [Lerer et al. (2003); Mol Psychiatry 8:488-498] detected significant evidence for linkage at chromosome 6q23. Subsequent fine mapping [Levi et al. (2005); Eur J Hum Genet 13:763-771], association [Amann-Zalcenstein et al. (2006); Eur J Hum Genet 14:1111-1119] and replication studies [Ingason et al. (2007); Eur J Hum Genet 15:988-991] identified AHI1 as a putative susceptibility gene. The same genome scan revealed suggestive evidence for a schizophrenia susceptibility locus in the 10q23-26 region. Genes at these two loci may act independently in the pathogenesis of the disease in our homogeneous sample of Arab Israeli families or may interact with each other and with other factors in a common biological pathway. The purpose of our current study was to test the hypothesis of genetic interaction between these two loci and to identify the type of interaction between them. The initial stage of our study focused on the 10q23-q26 region which has not been explored further in our sample. The second stage of the study included a test for possible genetic interaction between the 6q23.3 locus and the refined 10q24.33-q26.13 locus. A final candidate region of 19.9 Mb between markers D10S222 (105.3 Mb) and D10S587 (125.2 Mb) was found on chromosome 10 by non-parametric and parametric linkage analyses. These linkage findings are consistent with previous reports in the same chromosomal region. Two-locus multipoint linkage analysis under three complex disease inheritance models (heterogeneity, multiplicative, and additive models) yielded a best maximum LOD score of 7.45 under the multiplicative model suggesting overlapping function of the 6q23.3 and 10q24.33-q26.13 loci. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19152384     DOI: 10.1002/ajmg.b.30918

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  4 in total

Review 1.  Genetics of schizophrenia from a clinicial perspective.

Authors:  Prachi Kukshal; B K Thelma; Vishwajit L Nimgaonkar; Smita N Deshpande
Journal:  Int Rev Psychiatry       Date:  2012-10

2.  A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with schizophrenia.

Authors:  Andrés Ingason; Ina Giegling; Sven Cichon; Thomas Hansen; Henrik B Rasmussen; Jimmi Nielsen; Gesche Jürgens; Pierandrea Muglia; Annette M Hartmann; Eric Strengman; Catalina Vasilescu; Thomas W Mühleisen; Srdjan Djurovic; Ingrid Melle; Bernard Lerer; Hans-Jürgen Möller; Clyde Francks; Olli P H Pietiläinen; Jouko Lonnqvist; Jaana Suvisaari; Annamari Tuulio-Henriksson; Muriel Walshe; Evangelos Vassos; Marta Di Forti; Robin Murray; Chiara Bonetto; Sarah Tosato; Rita M Cantor; Marcella Rietschel; Nick Craddock; Michael J Owen; Leena Peltonen; Ole A Andreassen; Markus M Nöthen; David St Clair; Roel A Ophoff; Michael C O'Donovan; David A Collier; Thomas Werge; Dan Rujescu
Journal:  Hum Mol Genet       Date:  2010-01-12       Impact factor: 6.150

3.  Association of the type 2 diabetes mellitus susceptibility gene, TCF7L2, with schizophrenia in an Arab-Israeli family sample.

Authors:  Anna Alkelai; Lior Greenbaum; Sara Lupoli; Yoav Kohn; Kyra Sarner-Kanyas; Edna Ben-Asher; Doron Lancet; Fabio Macciardi; Bernard Lerer
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

4.  TCF7L2 polymorphisms and the risk of schizophrenia in the Chinese Han population.

Authors:  Lijun Liu; Jingjie Li; Mengdan Yan; Jing Li; Junyu Chen; Yi Zhang; Xikai Zhu; Li Wang; Longli Kang; Dongya Yuan; Tianbo Jin
Journal:  Oncotarget       Date:  2017-04-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.